Risedronate in children with osteogenesis imperfecta: a randomised, double-blind, placebo-controlled trial-Reference-Cited by-同舟云学术

Risedronate in children with osteogenesis imperfecta: a randomised, double-blind, placebo-controlled trial

Published:2013-10 Issue:9902 Volume:382 Page:1424-1432
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Bishop Nick,Adami Silvano,Ahmed S Faisal,Antón Jordi,Arundel Paul,Burren Christine P,Devogelaer Jean-Pierre,Hangartner Thomas,Hosszú Eva,Lane Joseph M,Lorenc Roman,Mäkitie Outi,Munns Craig F,Paredes Ana,Pavlov Helene,Plotkin Horacio,Raggio Cathleen L,Reyes Maria Loreto,Schoenau Eckhard,Semler Oliver,Sillence David O,Steiner Robert D

Publisher

Elsevier BV

Subject

General Medicine

Reference29 articles.

1. Genetic heterogeneity in osteogenesis imperfecta;Sillence;J Med Genet,1979

2. Osteogenesis imperfecta: a genetic, radiological, and epidemiological study;Andersen;Clin Genet,1989

3. Hearing loss in children with osteogenesis imperfecta;Kuurila;Eur J Pediatr,2000

4. Characterising and treating osteogenesis imperfecta;Bishop;Early Hum Dev,2010

5. Primary osteoporosis;Bishop,2009

Cited by 161 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Midterm Outcomes of Multimodal Approach to Treating Severe Scoliosis in Patients With Osteogenesis Imperfecta;Journal of the American Academy of Orthopaedic Surgeons;2024-07-10

2. Clinical spectrum of rare bone fragility disorders and response to bisphosphonate treatment: a retrospective study;European Journal of Human Genetics;2024-06-26

3. Dickkopf-1 (DKK1) blockade mitigates osteogenesis imperfecta (OI) related bone disease;Molecular Medicine;2024-05-21

4. Correlation of serum DKK1 level with skeletal phenotype in children with osteogenesis imperfecta;Journal of Endocrinological Investigation;2024-05-14

5. Optimising Health-Related Quality of Life in Children With Osteogenesis Imperfecta;Calcified Tissue International;2024-05-02